VitroScreen

VitroScreen is a privately owned Research Laboratory founded in 2001. It provides predictive, biologically relevant and reproducible pre-clinical testing strategy for life sciences. VitroScreen has been one of the key player in the introduction and acceptance of in vitro pre-clinical studies and continues to develop and validate new in vitro models with the aim to improve the wellbeing of our community and make the environment we live in a safer and better place. VitroScreen is committed to Alternatives and it is member of EU NETVAL laboratories network since 2014. VitroScreen has so far developed 500+ unique experimental models for efficacy...

In vitro toxicology,gene expression,glp studies,human tissues,biomarkers,3d tissue model,tissue atrophy,inflammation,cell,pharmacology,dermatology,cosmetic,toxicology,skin,research,nonanimaltesting,testingforlife,microbiome,preclinicaltesting,medicaldevices,foodsupplements,chemical,and drugs

Vitroscreen operates in the Biotechnology research industry.

Vitroscreen's revenue is 11m - 100m

Vitroscreen has 11 - 50 employees.